Evoq Remedies

Evoq_Remedies06 May 2024

Trading

₹

-0.24 (-2.28%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Evoq Remedies

Evoq Remedies

Trading

Evoq_Remedies06 May 2024

₹

-0.24 (-2.28%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
03-Feb-2024	BC	Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held	28-Feb-2024
03-Feb-2024	BC	Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held	03-Feb-2024
03-Feb-2024	BC	Announcement under Regulation 30 (LODR) 2015 Appointment of Managing Director Intimation under Regulation 30 (LODR), 2015 for appointment of Company Secretary and Compliance officer	03-Feb-2024
16-Jan-2024	BC	Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve and discuss proposal of raising of funds by	22-Jan-2024
12-Jan-2024	BC	Payal Bhumishth Patel	11-Jan-2024

No Rights has been declared by Evoq_Remedies

Book Closure

Record Date	Split Date	Purpose
28-Feb-2024	-	Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held
03-Feb-2024	-	Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held
03-Feb-2024	-	Announcement under Regulation 30 (LODR) 2015 Appointment of Managing Director Intimation under Regulation 30 (LODR), 2015 for appointment of Company Secretary and Compliance officer
22-Jan-2024	-	Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve and discuss proposal of raising of funds by
11-Jan-2024	-	Payal Bhumishth Patel

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Evoq Remedies Ltd ₹10.29(-0.24/-2.28%)	10.29	-0.24	13.99	-21.63	8.65	0.56
Computer Point Ltd ₹4.92(-0.17/-3.34%)	4.92	-0.17	14.76	143.56	492.00	0.44
Ambalal Sarabhai Enterprises Ltd ₹44.88(-0.59/-1.30%)	44.88	-0.59	343.93	99.02	0.00	9.45
Novartis India Ltd ₹1,062.00(+4.75/0.45%)	1,062.00	+4.75	2,622.16	77.73	27.45	3.73
Mysore Petro Chemicals Ltd ₹180.70(-3.20/-1.74%)	180.70	-3.20	118.96	58.86	15.93	1.16
Aegis Logistics Ltd ₹603.85(-25.45/-4.04%)	603.85	-25.45	21,195.14	52.10	48.04	9.55

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	3.09	0.03	0.00	0.02	0.01
Net Cash from Operating Activities	-4.35	-26.43	0.03	-0.02	0.01
Net Cash Used In Investing Activities	-0.01	0.00	0.00	0.00	0.00
Net Cash Used In Financing Activities	1.42	29.49	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	-2.94	3.06	0.03	-0.02	0.01
Cash And Cash Equivalents At End Of The Year	0.15	3.09	0.03	0.00	0.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

20.53%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

79.47%

**Promoter pledged shareholding 20.53%

About Evoq Remedies Ltd

Evoq Remedies Ltd is in the Trading sector, having a market capitalization of Rs. 13.99 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes , Payal Bhumishth Patel,Tarunkumar Gunvantlal Patel,Pranav Manoj Vajani,Digesh Deshaval,Dahyabhai Patel,Bhumishth Narendrabhai Patel,Narendrakumar Gangaramdas Patel (Evoq Remedies Ltd) among others.

Chairman

Registered office

F-12-A 1st Floor V R Complex,Nr.Sanathal Cross Road Santhal,Ahmedabad,Gujarat,382210

FAX :

Background

Incorporation Year2010

Face Value₹10

Market Lot4000

How to buy Evoq Remedies shares on nse?

To buy Evoq Remedies shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Evoq Remedies share price today?

The Evoq Remedies shares price on nse is Rs.10.29 today.

What is the market cap of Evoq Remedies shares on BSE ?

The company has a market capitalization of Rs.13.99Cr

What is the PE & PB ratio of Evoq Remedies shares ?

PE is 8.65 and PB is 0.56

What is the 52 Week High and Low of Evoq Remedies shares?

Evoq Remedies stock price high: Rs.19.44 Evoq Remedies stock price low: Rs.8.5